CompoAtlas

Somny Recovery

Food supplement declared in France, decision dated 8 October 2026

Somny Recovery is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
WAYBIO LABORATOIRE
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
6 gélules
Directions for use
6 gélules le soir.
Intended populations
Femmes enceintes
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil

Declaration 373491, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Valeriana officinalis L.RacinePoudre (de plantes séchées ou broyées)360 mg
Eschscholzia californica Cham.Parties aériennesExtrait sec hydroalcoolique360 mg
Papaver rhoeas L.FleurPoudre (de plantes séchées ou broyées)360 mg

Other active ingredients

NamePer day
Phospholipidesnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Levure enrichie en séléniumSélénium255 µg50 µg

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l’adulte. Déconseillé aux femmes enceintes ou allaitantes.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line